Article
Genetic analysis of patients with defects in early B-cell development.
Immunological reviews - 1 Feb 2005
Conley Mary Ellen, Broides Arnon, Hernandez-Trujillo Vivian, Howard Vanessa, Kanegane Hirokazu, Miyawaki Toshio, Shurtleff Sheila A
Abstract excerpt
Approximately 85% of patients with defects in early B-cell development have X-linked agammaglobulinemia (XLA), a disorder caused by mutations in the cytoplasmic Bruton's tyrosine kinase (Btk). Although Btk is activated by cross-linking of a variety of cell-surface receptors, the most critical signal transduction pathway is the one initiated by the pre-B cell and B-cell antigen receptor complex. Mutations in Btk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
